Paramesu Biotech Limited is among India’s largest manufacturers of maize-based speciality products for food, animal nutrition, paper, and other industrial uses (F&S Report). Its diversified portfolio includes native and modified maize starches, liquid glucose, maltodextrin powder, and co-products such as germs, gluten, fiber, corn steep liquor, and enriched fiber, catering to a wide range of industries and applications.
Price Band₹0.00 |
Dates- |
GMP₹0 (-) |
Subscriptions- |
Issue Size₹600.00 Crs |
Price Band₹0.00 |
Listing AtNSE & BSE |
IPO Issue Type100% Book Built Offer |
Fresh Issue₹520.00 Cr (0.00 Shares) |
Offer For Sale₹80.00 Cr (0.00 Shares) |
Total Issue₹600.00 Cr (0.00 Shares) |
Face Value₹5 per equity share |
Investor Category | Lot | Shares | Amount | |
---|---|---|---|---|
Retail |
Minimum
1
0
0
Maximum
-
-
-
|
|||
Small HNI |
Minimum
-
-
-
Maximum
-
-
-
|
|||
Big HNI |
Minimum
-
-
-
|
The estimated Grey Market Premium of Paramesu Biotech IPO is ₹0 per share (-)
Particulars | Allocation |
---|---|
QIBs | Not more than 50% of Net Offer |
Big HNIs (NII) | Not less than 10% of Net Offer |
Small HNIs (NII) | Not less than 5% of Net Offer |
Retail | Not less than 35% of Net Offer |
Particulars | Sep-24 | Mar-24 | Mar-23 | Mar-22 |
---|---|---|---|---|
Revenue from Operations | 407.59 | 627.85 | 623.93 | 494.91 |
Profit after Tax | 26.85 | 40.34 | 32.52 | 33.97 |
Net Worth | 200.10 | 173.12 | 132.96 | 100.95 |
Total Borrowing | 216.18 | 205.88 | 140.56 | 81.98 |
Total Assets | 479.44 | 439.68 | 319.17 | 238.88 |
NAV per share (in ₹) | 7.62 | 6.59 | 5.06 | 3.84 |
EPS - Basic (in ₹) | 1.02 | 1.54 | 1.24 | 1.29 |
The financial information presented is on a consolidated basis.
KPI | KPI |
---|---|
EBITDA | 12.19% |
PAT | 6.41% |
ROE | 23.30% |
ROCE | 18.13% |
Debt to Equity | 1.19% |
.
.
Name | Shareholding |
---|---|
Unimark Business Solutions Pvt Ltd | 82.01% |
Mani Tetali | 3.55% |
Ananda Adavani | 3.31% |
Himabindu Tetali | 2.81% |
Other Promoter | 0.51% |
Total | 92.19% |
Name | Designation |
---|---|
Ananda Adavani | MD |
Satya Veeravilli | CFO |
Name: Paramesu Biotech Limited
Address: RS No. 972, 3rd KM on Gopalapuram Road, West Godavari, Devarapalli – 534 313, Andhra Pradesh, India.
Number: 0883 2945700
Email:: cs@paramesu.com
Website: www.paramesu.com
Find answers to common questions that come in your mind related to IPO.
Paramesu Biotech IPO is a Mainboard IPO having an issue size of Rs. ₹600.00 Crs. Paramesu Biotech IPO is priced at ₹0.00 - ₹0.00 per share. The issue opens on 08 Sep 25 and closes on 08 Sep 25.
Paramesu Biotech IPO opens on 08 Sep 25 and closes on 08 Sep 25.
The estimated Grey Market Premium of Paramesu Biotech IPO is ₹0 per share (-).
The minimum lot size of Paramesu Biotech IPO is 0.00 shares & the minimum application amount is Rs. 0.
The allotment date of Paramesu Biotech IPO is 08 Sep 25.
The listing date of Paramesu Biotech IPO is 08 Sep 25.
Paramesu Biotech IPO is subscribed -.
Paramesu Biotech IPO is priced at ₹0.00 - ₹0.00 per share.
Click the allotment link on Paramesu Biotech IPO page of IPO360.